Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.16%
EBIT Growth (5y)
9.02%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-0.75%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
32
Price to Book Value
3.15
EV to EBIT
29.76
EV to EBITDA
29.76
EV to Capital Employed
3.15
EV to Sales
29.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.18%
ROE (Latest)
0.95%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
No Data found
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-2What is not working for the Company
PBDIT(Q)
Lowest at Rs 0.04 cr.
PBT LESS OI(Q)
Lowest at Rs 0.04 cr.
Loading Valuation Snapshot...
Here's what is not working for Omkar Pharmachem
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 0.04 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.04 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
